1-5 of 5
Olivier Adotevi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Plasma CD27, a Surrogate of the Intratumoral CD27–CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma

Available to Purchase
Nadine Benhamouda, Ikuan Sam, Nicolas Epaillard, Alain Gey, Letuan Phan, Hang Phuong Pham, Nadège Gruel, Antonin Saldmann, Joséphine Pineau, Milena Hasan, Valentin Quiniou, Camille Nevoret, Virginie Verkarre, Valentina Libri, Sebastien Mella, Clémence Granier, Chloe Broudin, Patrice Ravel, Eléonore De Guillebon, Laetitia Mauge, Dominique Helley, Bernd Jabla, Nathalie Chaput, Laurence Albiges, Sandrine Katsahian, Julien Adam, Arnaud Mejean, Olivier Adotevi, Yann A. Vano, Stéphane Oudard, Eric Tartour
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (22): 4983–4994.
https://doi.org/10.1158/1078-0432.CCR-22-0905
Published: 14 November 2022
View article titled, Plasma CD27, a Surrogate of the Intratumoral CD27–CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma
Open the PDF for Plasma CD27, a Surrogate of the Intratumoral CD27–CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors

Available to Purchase
Luis Teixeira, Jacques Medioni, Julie Garibal, Olivier Adotevi, Ludovic Doucet, Marie-Agnès Dragon Durey, Zineb Ghrieb, Jean-Jacques Kiladjian, Mara Brizard, Caroline Laheurte, Maria Wehbe, Elodie Pliquet, Marie Escande, Rémy Defrance, Stephane Culine, Stephane Oudard, Simon Wain-Hobson, Valérie Doppler, Thierry Huet, Pierre Langlade-Demoyen
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (3): 588–597.
https://doi.org/10.1158/1078-0432.CCR-19-1614
Published: 03 February 2020
View article titled, A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors
Open the PDF for A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

High-throughput Screening of Human Tumor Antigen–specific CD4 T Cells, Including Neoantigen-reactive T Cells

Free
Carla Costa-Nunes, Amélie Cachot, Sara Bobisse, Marion Arnaud, Raphael Genolet, Petra Baumgaertner, Daniel E. Speiser, Pedro M. Sousa Alves, Federico Sandoval, Olivier Adotévi, Walter Reith, Maria Pia Protti, George Coukos, Alexandre Harari, Pedro Romero, Camilla Jandus
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (14): 4320–4331.
https://doi.org/10.1158/1078-0432.CCR-18-1356
Published: 15 July 2019
View article titled, High-throughput Screening of Human Tumor Antigen–specific CD4 T Cells, Including Neoantigen-reactive T Cells
Open the PDF for High-throughput Screening of Human Tumor Antigen–specific CD4 T Cells, Including Neoantigen-reactive T Cells in another window
Includes: Supplementary data
Journal Articles

Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor

Free
Magalie Dosset, Yann Godet, Charline Vauchy, Laurent Beziaud, Yu Chun Lone, Christine Sedlik, Christelle Liard, Emeline Levionnois, Bertrand Clerc, Federico Sandoval, Etienne Daguindau, Simon Wain-Hobson, Eric Tartour, Pierre Langlade-Demoyen, Christophe Borg, Olivier Adotévi
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (22): 6284–6295.
https://doi.org/10.1158/1078-0432.CCR-12-0896
Published: 14 November 2012
View article titled, Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
Open the PDF for Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor in another window
Includes: Supplementary data
Journal Articles

Analysis of Spontaneous Tumor-Specific CD4 T-cell Immunity in Lung Cancer Using Promiscuous HLA-DR Telomerase-Derived Epitopes: Potential Synergistic Effect with Chemotherapy Response

Free
Yann Godet, Elizabeth Fabre, Magalie Dosset, Michele Lamuraglia, Emeline Levionnois, Patrice Ravel, Nadine Benhamouda, Aurélie Cazes, Françoise Le Pimpec-Barthes, Beatrice Gaugler, Pierre Langlade-Demoyen, Xavier Pivot, Philippe Saas, Bernard Maillère, Eric Tartour, Christophe Borg, Olivier Adotévi
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (10): 2943–2953.
https://doi.org/10.1158/1078-0432.CCR-11-3185
Published: 14 May 2012
View article titled, Analysis of Spontaneous Tumor-Specific CD4 T-cell Immunity in Lung Cancer Using Promiscuous HLA-DR Telomerase-Derived Epitopes: Potential Synergistic Effect with Chemotherapy Response
Open the PDF for Analysis of Spontaneous Tumor-Specific CD4 T-cell Immunity in Lung Cancer Using Promiscuous HLA-DR Telomerase-Derived Epitopes: Potential Synergistic Effect with Chemotherapy Response in another window
Includes: Supplementary data